The need for urogenital tract monitoring in COVID-19

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2, which invades a cell through binding to the ACE2 receptor and TMPRSS2 priming. Patients with severe disease predominantly present with pneumonia-related symptoms. However, evidence suggests that COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shangqian, Zhou, Xiang, Zhang, Tongtong, Wang, Zengjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186932/
https://www.ncbi.nlm.nih.gov/pubmed/32313110
http://dx.doi.org/10.1038/s41585-020-0319-7
_version_ 1783527059971112960
author Wang, Shangqian
Zhou, Xiang
Zhang, Tongtong
Wang, Zengjun
author_facet Wang, Shangqian
Zhou, Xiang
Zhang, Tongtong
Wang, Zengjun
author_sort Wang, Shangqian
collection PubMed
description Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2, which invades a cell through binding to the ACE2 receptor and TMPRSS2 priming. Patients with severe disease predominantly present with pneumonia-related symptoms. However, evidence suggests that COVID-19 infection also has implications for the urogenital tract. Thus, urogenital organs should be considered when treating COVID-19.
format Online
Article
Text
id pubmed-7186932
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-71869322020-04-28 The need for urogenital tract monitoring in COVID-19 Wang, Shangqian Zhou, Xiang Zhang, Tongtong Wang, Zengjun Nat Rev Urol Comment Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2, which invades a cell through binding to the ACE2 receptor and TMPRSS2 priming. Patients with severe disease predominantly present with pneumonia-related symptoms. However, evidence suggests that COVID-19 infection also has implications for the urogenital tract. Thus, urogenital organs should be considered when treating COVID-19. Nature Publishing Group UK 2020-04-20 2020 /pmc/articles/PMC7186932/ /pubmed/32313110 http://dx.doi.org/10.1038/s41585-020-0319-7 Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Comment
Wang, Shangqian
Zhou, Xiang
Zhang, Tongtong
Wang, Zengjun
The need for urogenital tract monitoring in COVID-19
title The need for urogenital tract monitoring in COVID-19
title_full The need for urogenital tract monitoring in COVID-19
title_fullStr The need for urogenital tract monitoring in COVID-19
title_full_unstemmed The need for urogenital tract monitoring in COVID-19
title_short The need for urogenital tract monitoring in COVID-19
title_sort need for urogenital tract monitoring in covid-19
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186932/
https://www.ncbi.nlm.nih.gov/pubmed/32313110
http://dx.doi.org/10.1038/s41585-020-0319-7
work_keys_str_mv AT wangshangqian theneedforurogenitaltractmonitoringincovid19
AT zhouxiang theneedforurogenitaltractmonitoringincovid19
AT zhangtongtong theneedforurogenitaltractmonitoringincovid19
AT wangzengjun theneedforurogenitaltractmonitoringincovid19
AT wangshangqian needforurogenitaltractmonitoringincovid19
AT zhouxiang needforurogenitaltractmonitoringincovid19
AT zhangtongtong needforurogenitaltractmonitoringincovid19
AT wangzengjun needforurogenitaltractmonitoringincovid19

Ejemplares similares